المؤلفون: Barele, M. van, Rieborn, A., Heemskerk-Gerritsen, B.A.M., Obdeijn, I.M., Koppert, L.B., Loo, C.E., Tollenaar, R.A.E.M., Ausems, M.G.E.M., Beek, I. van de, Berger, L.P.V., Boer, M. de, Hest, L.P. van, Kets, C.M., Rookus, M., Hebon, Schmidt, M.K., Jager, A., Hooning, M.J.

المساهمون: Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Medical Oncology, Radiology & Nuclear Medicine, Surgery, Human genetics, Cancer Center Amsterdam, CCA - Cancer Treatment and quality of life

المصدر: Breast Cancer Research and Treatment, 194, 1, pp. 159-170
Breast Cancer Research and Treatment, 194(1), 159-170. Springer, Cham
Breast Cancer Research and Treatment, 194(1), 159-170. Springer New York
Breast Cancer Research and Treatment, 194(1), 159-170. SPRINGER
HEBON 2022, ' Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study ', Breast Cancer Research and Treatment, vol. 194, no. 1, pp. 159-170 . https://doi.org/10.1007/s10549-022-06608-1Test
Breast Cancer Research and Treatment, 194, 159-170

مصطلحات موضوعية: Cancer Research, PREDICTOR, Survival, Breast Neoplasms, Cohort Studies, Breast cancer, SDG 3 - Good Health and Well-being, STAGE, BRCA2 MUTATION CARRIERS, MANAGEMENT, Humans, Breast, BRCA2 Protein, OUTCOMES, BRCA1 Protein, LYMPH-NODE METASTASIS, WOMEN, Tumor size, Prognosis, BRCA1, BRCA2, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Oncology, Mutation, Female, SUBTYPE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b553cea35fcbc23d4428aaf062d6c6Test
https://doi.org/10.1007/s10549-022-06608-1Test

المؤلفون: Osnat Halshtok, Nayroz Kanana, Renata Faermann, Eitan Friedman, Noam Nissan, Meirav A Ben David, Eyal Klang, Dov Zippel, Orit Kaidar-Person, Mohammad Yassin, David Samoocha, Yael Yagil, Miri Sklair Levy, Anat Shalmon, Michael Gotlieb, Tima Davidson, Dana Madorsky Feldman

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie

المصدر: Breast journal, 27(5), 441-447. Wiley-Blackwell

مصطلحات موضوعية: Heterozygote, medicine.medical_specialty, endocrine system diseases, Breast imaging, medicine.medical_treatment, Genes, BRCA2, surveillance scheme, Breast Neoplasms, Disease, Asymptomatic, 030218 nuclear medicine & medical imaging, breast cancer risk, 03 medical and health sciences, brca1, 0302 clinical medicine, Breast cancer, Post mastectomy, risk‐, Internal Medicine, Humans, Medicine, skin and connective tissue diseases, mri, Retrospective Studies, BRCA2 Protein, BRCA2 mutation carriers, BRCA1 Protein, business.industry, mastectomy, reducing surgery, Retrospective cohort study, medicine.disease, Surgery, Oncology, 030220 oncology & carcinogenesis, Mutation, Mutation (genetic algorithm), Female, medicine.symptom, business, Mastectomy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05621115b7d4c5694c6a4b9e15433a9fTest
https://doi.org/10.1111/tbj.14190Test

المؤلفون: Carrie Snyder, Angie Fairchild, Geoffrey J. Lindeman, D. Gareth Evans, Kelly A. Metcalfe, Alexander Liede, Sue Friedman, Melanie A. Price, Joshua Posner, Henry T. Lynch, Steven A. Narod, Carol Mansfield, David Hallett

المصدر: British Journal of Cancer
Metcalfe, K, Price, M, Mansfield, C A, Hallett, D C, Lindeman, G J, Fairchild, A, Posner, J, Friedman, S, Snyder, C, Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Lynch, H T, Evans, D G, Narod, S A & Liede, A 2020, ' Predictors of Long-Term Cancer-Related Distress Among Female BRCA1 and BRCA2 Mutation Carriers Without a Cancer Diagnosis: An International Analysis ', British Journal of Cancer. . https://doi.org/10.1038/s41416-020-0861-3Test

مصطلحات موضوعية: Adult, Cancer Research, medicine.medical_specialty, Canada, Heterozygote, Breast Neoplasms, 030230 surgery, Predictive markers, Psychological Distress, Article, Cancer prevention, 03 medical and health sciences, 0302 clinical medicine, BRCA2 Mutation, Breast cancer, Risk Factors, Medicine, Humans, Genetic Testing, BRCA2 Protein, Ovarian Neoplasms, business.industry, Obstetrics, BRCA1 Protein, Cancer related distress, BRCA mutation, Australia, Cancer, distress, Middle Aged, medicine.disease, BRCA1, BRCA2, United Kingdom, Distress, predictors, Oncology, 030220 oncology & carcinogenesis, Positive test result, Mutation, psychosocial functioning, Female, Cancer risk, business, Event scale

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266072ec3ecbba8ef763bebb1e94b6f3Test
http://europepmc.org/articles/PMC7374749Test

المؤلفون: Shyam K. Sharan, Kajal Biswas

المصدر: Molecular Oncology, Vol 14, Iss 6, Pp 1121-1123 (2020)
Molecular Oncology

مصطلحات موضوعية: 0301 basic medicine, Cytoplasm, Cancer Research, endocrine system diseases, DNA Repair, genetic processes, RAD52, Mice, 0302 clinical medicine, BRCA2 Mutation, Risk Factors, skin and connective tissue diseases, Research Articles, Ovarian Neoplasms, BRCA1 Protein, DNA, Neoplasm, General Medicine, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Research Article, Subcellular Fractions, Heterozygote, DNA repair, Breast Neoplasms, Biology, lcsh:RC254-282, 03 medical and health sciences, breast cancer, Breast cancer, Cell Line, Tumor, Genetics, medicine, Animals, Humans, Genetic Predisposition to Disease, Genetic Association Studies, Germ-Line Mutation, BRCA2 Protein, fungi, medicine.disease, BRCA2, Rad52 DNA Repair and Recombination Protein, enzymes and coenzymes (carbohydrates), Germ Cells, 030104 developmental biology, Mutation, double‐strand break repair, Commentary, Cancer research, Homologous recombination, Nuclear localization sequence

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd1753eb1eacda14f55439f503e60eadTest
https://doi.org/10.1002/1878-0261.12679Test

المؤلفون: Marion Gauthier-Villars, Daniel Barrowdale, Matti A. Rookus, Douglas F. Easton, Nadine Andrieu, Mary Beth Terry, Bcfr, Louise Izatt, Jackie Cook, Maartje J. Hooning, T.M. Mooij, Marian J.E. Mourits, Bernadette A. M. Heemskerk-Gerritsen, Rita K. Schmutzler, Diana Eccles, Roger L. Milne, Javier Benitez, Alex Henderson, Catherine Noguès, Brita Arver, Marc Tischkowitz, Linetta B. Koppert, Carole Brewer, Flora E. van Leeuwen, Margreet G. E. M. Ausems, Antonis C. Antoniou, John L. Hopper, Christian F. Singer, Anne-Marie Gerdes, Jacques Simard, Irene L. Andrulis, David E. Goldgar, Anna Jakubowska, Saundra S. Buys, Pascal Pujol, Alain Lortholary, Marie Navratilova, Paul Gesta, Ros Eeles, Håkan Olsson, Yen Y. Tan, Trinidad Caldés, Debra Frost, Mary B. Daly, D. Gareth Evans, Edith Olah, Kelly-Anne Phillips, Karin Kast, Christoph Engel, Wendy K. Chung, Klaartje van Engelen, Esther M. John, Julian Adlard, Marie Jose Roos-Blom, Nasim Mavaddat, Olivier Caron, Lenka Foretova

المصدر: Breast Cancer Research, Vol 22, Iss 1, Pp 1-3 (2020)
Breast Cancer Research : BCR

مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, Salpingo-oophorectomy, Breast Neoplasms, lcsh:RC254-282, Cohort Studies, BRCA2 Mutation, Breast cancer, Internal medicine, medicine, Humans, Prospective Studies, Prospective cohort study, BRCA2 Protein, Natural menopause, business.industry, BRCA1 Protein, Incidence, Correction, International Agencies, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Mutation, Female, Menopause, business, Risk Reduction Behavior

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4908f25cd9d807d2c09bbd48d64a7eTest
http://link.springer.com/article/10.1186/s13058-020-01259-wTest

المؤلفون: Gabriela Carvalho Fernandes, Paula Silva Felicio, Cristovam Scapulatempo-Neto, Rodrigo Augusto Depieri Michelli, Edenir Inêz Palmero, Aline Silva Coelho

المصدر: Asian Pacific Journal of Cancer Prevention : APJCP

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, medicine.medical_specialty, endocrine system diseases, Population, Breast Neoplasms, BRCA1 vs. BRCA2 mutated patients, family history of cancer, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Genetic Predisposition to Disease, Genetic Testing, Family history, skin and connective tissue diseases, education, Hereditary breast cancer, Genetic testing, BRCA2 Protein, Ovarian Neoplasms, education.field_of_study, medicine.diagnostic_test, BRCA1 Protein, business.industry, Incidence, Cancer, General Medicine, Middle Aged, Prognosis, medicine.disease, Tumor Pathology, BRCA2 Mutation Carrier, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation, Immunohistochemistry, Female, Ovarian cancer, business, Brazil, Research Article, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b52f34eb465dd49658bda4a9386841aeTest
https://doi.org/10.31557/apjcp.2019.20.6.1655Test

المؤلفون: Xuan-Anh Phi, Marcel J. W. Greuter, Nehmat Houssami, Inge-Marie Obdeijn, Talitha L Feenstra, Jan C. Oosterwijk, Geertruida H. de Bock

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Life Course Epidemiology (LCE), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Radiology & Nuclear Medicine

المصدر: The Breast, 45, 82-88. Churchill Livingstone
Breast, 45, 82-88. Churchill Livingstone
The Breast

مصطلحات موضوعية: Pediatrics, GUIDELINES, Breast cancer screening, Brca1 2 mutation, 0302 clinical medicine, BRCA2 Mutation, HISTORY, 030212 general & internal medicine, skin and connective tissue diseases, Early Detection of Cancer, MAMMOGRAPHIC DENSITY, health care economics and organizations, Netherlands, medicine.diagnostic_test, Tumor size, BRCA1 Protein, Breast neoplasm, Cost-benefit analysis, General Medicine, Cost-effectiveness analysis, Middle Aged, CARRIERS, Magnetic Resonance Imaging, 030220 oncology & carcinogenesis, Screening, Life years gained, GROWTH, Female, Quality-Adjusted Life Years, SENSITIVITY, Mammography, medicine.medical_specialty, Breast Neoplasms, Risk Assessment, 1117 Public Health and Health Services, 03 medical and health sciences, Breast cancer, SDG 3 - Good Health and Well-being, medicine, Humans, 1112 Oncology and Carcinogenesis, Genetic Predisposition to Disease, Aged, BRCA2 Protein, business.industry, HORMONE REPLACEMENT THERAPY, BRCA1, medicine.disease, BRCA2, RISKS, Mutation, Surgery, FOLLOW-UP, business, FILM

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da9eb90d93c25b5d7473519423c4e22Test
https://doi.org/10.1016/j.breast.2019.03.004Test

المؤلفون: Mitsue Saito, Mizuho Kita, Masami Arai, Eri Nakashima, Rie Horii, Reiko Yoshida, Satoko Shimada, Futoshi Akiyama, Shinji Ohno, Dai Kitagawa, Yuumi Ashihara, Sayoko Takeuchi, Naoya Gomi

المصدر: Breast Cancer (Tokyo, Japan)

مصطلحات موضوعية: 0301 basic medicine, Oncology, endocrine system diseases, Genes, BRCA2, Genes, BRCA1, Case Report, Disease, 0302 clinical medicine, Surgical oncology, Mass Screening, Pharmacology (medical), skin and connective tissue diseases, Early Detection of Cancer, Mastectomy, medicine.diagnostic_test, BRCA1 Protein, Incidence (epidemiology), General Medicine, Middle Aged, Magnetic Resonance Imaging, Breast cancer incidence, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Mammography, Adult, Risk, Screening-detected breast cancer, medicine.medical_specialty, Breast Neoplasms, BRCA2 mutation carrier, 03 medical and health sciences, Breast cancer, Internal medicine, medicine, Humans, Genetic Predisposition to Disease, Radiology, Nuclear Medicine and imaging, Genetic Testing, Tokyo, BRCA1 mutation carrier, Genetic testing, BRCA2 Protein, business.industry, BRCA mutation, medicine.disease, 030104 developmental biology, Mutation, Ovarian cancer, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d60b93408569b618e7cdc6767239c7Test
https://doi.org/10.1007/s12282-019-00971-6Test

المؤلفون: Martin Jakob Larsen, Torben A Kruse, Anne-Marie Gerdes, Jens Ole Eriksen, Anne-Vibeke Lænkholm, M B Jensen, Mads Thomassen, Ida Marie Heeholm Sonderstrup, Bent Ejlertsen

المصدر: Sønderstrup, I M H, Jensen, M B, Ejlertsen, B, Eriksen, J O, Gerdes, A M, Kruse, T A, Larsen, M J, Thomassen, M & Laenkholm, A V 2019, ' Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer ', Acta Oncologica, vol. 58, no. 3, pp. 363-370 . https://doi.org/10.1080/0284186X.2018.1539239Test

مصطلحات موضوعية: Adult, Disease free survival, Adolescent, endocrine system diseases, Breast Neoplasms, Disease-Free Survival, 030218 nuclear medicine & medical imaging, Cohort Studies, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, BRCA2 Mutation, Breast cancer, Humans, Medicine, Radiology, Nuclear Medicine and imaging, skin and connective tissue diseases, Aged, BRCA2 Protein, BRCA1 Protein, business.industry, Tumor-infiltrating lymphocytes, Hematology, General Medicine, Middle Aged, Prognosis, medicine.disease, female genital diseases and pregnancy complications, Oncology, 030220 oncology & carcinogenesis, Mutation, Mutation (genetic algorithm), Cancer research, Female, business, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910a91f54ed55a499b740a3584e7aa6dTest
https://doi.org/10.1080/0284186x.2018.1539239Test

المؤلفون: Kelly-Anne Phillips, Maria Ekholm, Jacek Gronwald, Tomasz Huzarski, Roger L. Milne, D. Gareth Evans, Ping Sun, Nadine Tung, Jeffrey N. Weitzel, Leigha Senter, Claire Forde, Jan Lubinski, Cezary Cybulski, Robert Fruscio, Steven A. Narod, Dana Zakalik, Zerin Hyder, Kelly A. Metcalfe

المساهمون: Evans, D, Phillips, K, Milne, R, Fruscio, R, Cybulski, C, Gronwald, J, Lubinski, J, Huzarski, T, Hyder, Z, Forde, C, Metcalfe, K, Senter, L, Weitzel, J, Tung, N, Zakalik, D, Ekholm, M, Sun, P, Narod, S

المصدر: kConFab Investigators, Polish Hereditary Breast Cancer Consortium & The Hereditary Breast Cancer Clinical Study Group 2021, ' Survival from breast cancer in women with a BRCA2 mutation by treatment ', British Journal of Cancer . https://doi.org/10.1038/s41416-020-01164-1Test

مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Ovariectomy, BRCA, Breast Neoplasms, 03 medical and health sciences, 0302 clinical medicine, BRCA2 Mutation, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Humans, Prospective Studies, Stage (cooking), skin and connective tissue diseases, Germ-Line Mutation, Mastectomy, Aged, Retrospective Studies, BRCA2 Protein, Chemotherapy, Radiotherapy, business.industry, BRCA1 Protein, Medical record, Hazard ratio, Oophorectomy, Cancer, Middle Aged, medicine.disease, Prognosis, Combined Modality Therapy, Survival Rate, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, business, Receptors, Progesterone, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9c77ef6eb13a511a29f424e39fe62eTest
http://hdl.handle.net/10281/303932Test